Leading the pack is Gilead Sciences' HIV medication Biktarvy, which had U.S. sales revenue five times greater than the rest of the world. (Photo: David Paul Morris/Bloomberg)
Americans spent nearly twice as much on the 20 top-selling pharmaceuticals as the rest of the world combined last year, according to an analysis by the interest group Public Citizen.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
